Medicare Enrolled
Dr. Omar Najera, MD
Surgery · Schertz, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Najera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Najera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Najera
Dr. Omar Najera is a surgery specialist in Schertz, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Najera performed 3,645 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Najera received a total of $17,289 from 58 pharmaceutical and/or device companies across 988 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Najera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 2% volume in TX
$17,289 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,645
Medicare services
Top 2% in TX for surgery
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
811 | $45 | $78 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
669 | $2 | $9 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
638 | $121 | $255 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
332 | $100 | $147 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
308 | $3 | $15 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
249 | $35 | $61 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
218 | $24 | $68 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
122 | $53 | $85 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $88 | $179 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
55 | $61 | $214 |
| New patient office visit, complex (60-74 min) | 36 | $129 | $316 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
34 | $17 | $31 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
29 | $104 | $205 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
22 | $83 | $160 |
| Automated retinal imaging for disease detection Imaging of the retina to detect disease, featuring automated review and a report generated at the point of care. |
20 | $32 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $67 | $129 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,289
Total received (2018-2024)
Avg $2,470/year across 7 years
Top 17% in TX for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
988
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,343
2023
$2,412
2022
$4,059
2021
$3,940
2020
$3,326
2019
$155
2018
$53
Payments by company (2024)
Novo Nordisk Inc
$539
Dexcom, Inc.
$308
Lilly USA, LLC
$307
Insulet Corporation
$252
Mannkind Corporation
$239
Abbott Laboratories
$193
Amgen Inc.
$172
Medtronic, Inc.
$164
Radius Health, Inc.
$163
ABBVIE INC.
$148
SANOFI-AVENTIS U.S. LLC
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
BETA BIONICS, INC.
$85
Chiesi USA, Inc.
$63
Eisai Inc.
$61
Corcept Therapeutics
$44
Averitas Pharma Inc.
$41
Xeris Pharmaceuticals, Inc.
$40
Boston Scientific Corporation
$37
Esperion Therapeutics, Inc.
$33
CeQur Corporation
$30
IBSA Pharma Inc.
$29
Tandem Diabetes Care, Inc.
$24
Kyowa Kirin, Inc.
$24
Ascensia Diabetes Care Us Inc.
$21
Enterra Medical, Inc.
$20
Amneal Pharmaceuticals LLC
$16
RECORDATI_RARE_DISEASES_INC.
$16
PFIZER INC.
$16
Top 3 companies account for 34.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$3,484
Lilly USA, LLC
$1,063
Dexcom, Inc.
$983
IBSA Pharma Inc.
$959
Abbott Laboratories
$762
AstraZeneca Pharmaceuticals LP
$732
Boehringer Ingelheim Pharmaceuticals, Inc.
$631
Mannkind Corporation
$622
Amgen Inc.
$579
SANOFI-AVENTIS U.S. LLC
$516
Amarin Pharma Inc.
$493
Xeris Pharmaceuticals, Inc.
$443
Insulet Corporation
$437
Radius Health, Inc.
$396
Medtronic, Inc.
$360
ABBVIE INC.
$350
MannKind Corporation
$333
DEXCOM, INC.
$296
Janssen Pharmaceuticals, Inc
$289
Antares Pharma, Inc.
$265
RECORDATI_RARE_DISEASES_INC.
$259
Currax Pharmaceuticals LLC
$241
Zealand Pharma US, Inc.
$234
Amneal Pharmaceuticals LLC
$221
Tandem Diabetes Care, Inc.
$220
EUSA Pharma (US) LLC
$212
AbbVie Inc.
$203
Corcept Therapeutics
$164
CeQur Corporation
$118
Ipsen Biopharmaceuticals, Inc
$98
Esperion Therapeutics, Inc.
$87
BETA BIONICS, INC.
$85
Horizon Therapeutics plc
$83
Bayer Healthcare Pharmaceuticals Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$66
Chiesi USA, Inc.
$63
Acerus Pharmaceuticals Corporation
$62
Eisai Inc.
$61
Averitas Pharma Inc.
$60
GRT US Holding, Inc.
$59
Companion Medical, Inc.
$56
Nevro Corp.
$53
Intuity Medical Inc
$52
Ultragenyx Pharmaceutical Inc.
$49
Medtronic MiniMed, Inc.
$48
Kyowa Kirin, Inc.
$47
LIFESCAN, INC.
$45
PFIZER INC.
$40
Amryt Pharma Holdings Ltd
$38
Boston Scientific Corporation
$37
Alexion Pharmaceuticals, Inc.
$24
Merck Sharp & Dohme Corporation
$23
Ascensia Diabetes Care Us Inc.
$21
Becton, Dickinson and Company
$21
Enterra Medical, Inc.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Tolmar, Inc.
$14
Althera Pharmaceuticals LLC
$11
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LINZESS · Lenvima · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NEXLETOL · NOCDURNA · Natesto · OTREXUP · Omnipod · Otrexup · Ozempic · Pogo Automatic Blood Glucose Monitoring System · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SYNJARDY · SYNTHROID · Saxenda · Senza · Sogroya · Somatuline Depot · Sylvant · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · VANTA ADAPTIVESTIM · Vascepa · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Surgerists in nearby ZIP areas
280
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
LAUREL RIDGE TREATMENT CENTER
11.0 mi
11.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Najera is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Najera experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Najera performed 811 chronic care management, first 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Najera receive payments from pharmaceutical companies?
Yes. Dr. Najera received a total of $17,289 from 58 companies across 988 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Najera's costs compare to other surgerists in Schertz?
Dr. Najera's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Najera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Schertz
Browse surgerists in Schertz ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in TX
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in TX
Which TX surgerists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Dexcom, Inc. Payments to Doctors
See all physicians who received payments from Dexcom, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology